AEVIS Holding SA: GSMN SA : Development of competence centres in ophthalmology in partnership with Professor André Mermoud
AEVIS Holding SA / Schlagwort(e): Firmenübernahme
23.05.2014 07:00
Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR
---------------------------------------------------------------------------
Acquisition of a majority stake in Visionplus SA
Genolier Swiss Medical Network SA (GSMN) has the ambition to develop its
ophthalmic activities through the creation of regional competence centres.
The group of private clinics today announces the conclusion of a
partnership with Professor André Mermoud and the acquisition of a majority
stake in Visionplus SA, of which he is medical director. This company,
which will be renamed Genolier Swiss Ophthalmic Network SA, is active in
the field of ophthalmology, mainly at Clinique de Montchoisi in Lausanne.
GSMN wishes to develop this centre and open new ones. The creation of a
second centre has already started in Neuchâtel. All ophthalmic activity of
the group will be centralised in this new structure. GSMN is thrilled to
pursue and reinforce its partnership with Professor André Mermoud, who will
continue to exercise as an ophthalmic surgeon and will actively contribute
to the network's expansion.
GSMN wishes to develop its ophthalmic activity and today announces the
conclusion of a partnership with Professor André Mermoud. This partnership
is materialised through the acquisition of a majority stake in Visionplus
SA, founded in Lausanne by Professor André Mermoud, the renowned ophthalmic
specialist. Visionplus SA, which will be renamed Genolier Swiss Ophthalmic
Network SA, is active in the field of ophthalmology, mainly at Clinique de
Montchoisi in Lausanne. Visionplus yearly performs an important number of
surgical interventions in ophthalmology. The main eye affections treated
are glaucoma's and cataracts. Visionplus SA, which employs 12 people, has
realised a turnover of CHF 3.8 million in 2013. The consolidation of the
results of this new subsidiary within GSMN is foreseen for the second
semester of 2014.
The new company Genolier Swiss Ophthalmic Network SA will first handle the
development of the Centre d'Ophtalmologie at Clinique de Montchoisi in
Lausanne and at Hôpital de la Providence in Neuchâtel. Other centres will
be opened in other Swiss cities.
GSMN is thrilled to pursue and reinforce its partnership with Professor
André Mermoud. Medical director of Genolier Swiss Ophthalmic Network SA,
the latter will continue his activity as ophthalmic surgeon and will
actively participate to the opening of new centres.
By regrouping the ophthalmic activity of its clinics under Genolier Swiss
Ophthalmic Network SA, GSMN wishes to create medical and operational
synergies. The patients will continue to benefit from an optimal care and a
complete treatment of all eye pathologies by the best ophthalmic doctors
and surgeons. Ambulatory care is accessible to all patients, whatever their
insurance coverage is. Stationary care in GSMN's listed clinics is also
accessible to any patient, even with a basic insurance coverage.
For more information :
Press Service GSMN
presse@gsmn.ch
Tél. +41 (0)22 366 99 87
Genolier Swiss Medical Network SA (GSMN) is the second largest network of
private clinics in Switzerland and the only one present in the three
linguistic regions. Its growth strategy focuses on the creation of a
national network of clinics with a strong regional presence. GSMN's main
objective is to offer first class hospital care to Swiss and foreign
patients. The distinctive features of GSMN include its high quality
services, its brand value, a pleasant working environment and an
experienced management team with an entrepreneurial approach. GSMN operates
14 private clinics in Switzerland, with around 1'275 admitting physicians
and 2'700 employees. GSMN is a 100% subsidiary of AEVIS Holding SA, listed
on SIX Swiss Exchange.
Professor André Mermoud is an FMH specialist in ophthalmology and
ophthalmic surgery. He graduated from the Faculties of Medicine of the
University of Lausanne, the University of Cape Town in South Africa and the
Doheny Eye Institute (University of South California, Los Angeles). As an
ophthalmic surgeon and before developing his activity at Clinique de
Montchoisi, he became recognised in the field of diagnosis and treatment of
glaucoma, as physician assistant at the Hôpital Ophtalmique Jules Gonin in
Lausanne and as associate professor at the Faculty of Medicine of the
University of Lausanne.
23.05.2014 Mitteilung übermittelt durch die EQS Schweiz AG.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
EQS veröffentlicht regulatorische Mitteilungen, Medienmitteilungen
mit Kapitalmarktbezug und Pressemitteilungen.
Die EQS Gruppe verbreitet Finanznachrichten für über 1'300
börsenkotierte Unternehmen im Original und in Echtzeit.
Das Schweizer Nachrichtenarchiv ist abrufbar unter http://switzerland.eqs.com/de/News
---------------------------------------------------------------------------